Literature DB >> 11952991

Cytokine release in febrile non-haemolytic red cell transfusion reactions.

J-S Lin1, C-H Tzeng, T-C Hao, H-Y Hu, Y-T Ho, J-Y Lyou, J M Liu, C-H Ho, C-H Yung.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to elucidate the role and identity of cytokines involved in febrile non-haemolytic red cell transfusion reactions (FNHTRs).
MATERIALS AND METHODS: Eighty-one patients experiencing transfusion reactions after receiving packed red blood cells (RBCs) were divided into three groups, as follows, based on the reaction experienced: FNHTRs (n = 60); chills without fever (n = 8); and allergic reaction with urticaria (n = 13). The concentrations of interleukin (IL)-1beta, IL-6, IL-8 and tumour necrosis factor (TNF)-alpha were measured in the packed transfused unit and patients' plasma by using enzyme immunoassays. Wilcoxon's matched-pairs signed test was used to compare the difference in cytokine levels in patients' plasma before and after transfusion. The Kruskal-Wallis test was used first, followed by the Mann-Whitney test, to compare the pretransfusion cytokine levels in patients' plasma between groups and to compare the cytokine levels in packed RBCs transfused to each group of patients.
RESULTS: The age of the implicated packed RBC was 11.5 +/- 5.7 days. Significant increases were observed in IL-6 (P < 0.001) and IL-8 (P < 0.001) patients' plasma levels, but not in IL-1beta or TNF-alpha levels, in those patients exhibiting FNHTR. No changes were observed in the patients' plasma samples of the other groups. Cytokine levels in the RBC concentrate supernatants were not appreciably elevated.
CONCLUSIONS: Transfusion of packed RBCs may significantly increase intravascular levels of IL-6 and IL-8 in patients with FNHTRs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952991     DOI: 10.1046/j.1423-0410.2002.00159.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  10 in total

1.  Evaluation of haemoglobin, haematocrit, haemolysis, residual protein content and leucocytes in 345 red blood cell concentrates used for the treatment of patients with β-thalassaemia.

Authors:  Roberta Mancini; Leonardo Marinelli; Nadia Mirante; Assunta Gallo; Antonella Matteocci; Filomena Terlizzi; Maria Palange; Daniela Fioravanti; Lorella Donnini; Luca Pierelli
Journal:  Blood Transfus       Date:  2011-11-16       Impact factor: 3.443

Review 2.  Duration of red blood cell storage and inflammatory marker generation.

Authors:  Caroline Sut; Sofiane Tariket; Ming Li Chou; Olivier Garraud; Sandrine Laradi; Hind Hamzeh-Cognasse; Jerard Seghatchian; Thierry Burnouf; Fabrice Cognasse
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

3.  Microarray kit analysis of cytokines in blood product units and segments.

Authors:  Richard B Weiskopf; Rebecca Yau; Rosa Sanchez; Clifford Lowell; Pearl Toy
Journal:  Transfusion       Date:  2009-06-22       Impact factor: 3.157

4.  Release of cytokines in stored whole blood and red cell concentrate: Effect of leukoreduction.

Authors:  Rinku Shukla; Tanvi Patel; Snehalata Gupte
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

5.  Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction.

Authors:  Chih-Chun Chang; Tai-Chen Lee; Ming-Jang Su; Hsiu-Chen Lin; Fang-Yi Cheng; Yi-Ting Chen; Tzung-Hai Yen; Fang-Yeh Chu
Journal:  Oncotarget       Date:  2017-12-07

6.  Platelet concentrate and type II IL-1 receptor are risk factors for allergic transfusion reactions in children.

Authors:  Wenjing Hu; Li Feng; Meng Li; Ting Li; Yudong Dai; Xiaowei Wang
Journal:  Ital J Pediatr       Date:  2020-07-29       Impact factor: 2.638

Review 7.  Red cell transfusions and guidelines: a work in progress.

Authors:  Bruce D Spiess
Journal:  Hematol Oncol Clin North Am       Date:  2007-02       Impact factor: 3.722

8.  Does Multi-Strain Probiotic Supplementation Impact the Effort Capacity of Competitive Road Cyclists?

Authors:  Paulina Mazur-Kurach; Barbara Frączek; Andrzej T Klimek
Journal:  Int J Environ Res Public Health       Date:  2022-09-26       Impact factor: 4.614

Review 9.  Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness.

Authors:  Jennifer A Muszynski; Philip C Spinella; Jill M Cholette; Jason P Acker; Mark W Hall; Nicole P Juffermans; Daniel P Kelly; Neil Blumberg; Kathleen Nicol; Jennifer Liedel; Allan Doctor; Kenneth E Remy; Marisa Tucci; Jacques Lacroix; Philip J Norris
Journal:  Transfusion       Date:  2016-10-02       Impact factor: 3.157

10.  Evaluation of transfusion pyrexia: a review of differential diagnosis and management.

Authors:  Oladimeji P Arewa
Journal:  ISRN Hematol       Date:  2012-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.